# FDA 483 - Zhejiang Jiuzhou Pharmaceutical Co., Ltd. - September 10, 2026

Source: https://www.globalkeysolutions.net/records/483/zhejiang-jiuzhou-pharmaceutical-co-ltd/7f901124-3391-440f-b3ab-e7f6a1b7af7d

> FDA 483 for Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on September 10, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
- Inspection Date: 2026-09-10
- Product Type: drugs
- Office Name: Office of Biological Products Operations - Division I
- Summary: An FDA inspection of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. in Taizhou, Zhejiang, an API manufacturer, identified a significant deficiency in process validation. The firm's validation report for an active pharmaceutical ingredient failed to address instances where the upper confidence limits for unknown impurities and residual solvents exceeded specification limits in both intermediate and finished batches. This indicates a lack of adequate control over manufacturing processes and product quality.

## Related Documents

- [WARNING_LETTER - 2013-10-24](https://www.globalkeysolutions.net/records/warning_letter/zhejiang-jiuzhou-pharmaceutical-co-ltd/d6aee00f-a341-4a32-8adc-33ae5b663aa6)
- [483 - 2018-09-13](https://www.globalkeysolutions.net/records/483/zhejiang-jiuzhou-pharmaceutical-co-ltd/55a70b2a-fa59-44fb-8b86-fea3be7dcb7e)

## Related Officers

- [ Investigator ](https://www.globalkeysolutions.net/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)

Company: https://www.globalkeysolutions.net/companies/zhejiang-jiuzhou-pharmaceutical-co-ltd/6ff21ff3-4c18-4e07-9c38-79e499bfb8fa

Office: https://www.globalkeysolutions.net/offices/office-of-biological-products-operations-division-i/49c53dac-7724-4c8c-8708-4f5779ea69c1